Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$122.71 - $146.91 $688,034 - $823,724
5,607 Added 33.54%
22,323 $3.19 Million
Q1 2024

May 07, 2024

BUY
$102.11 - $135.92 $1.42 Million - $1.88 Million
13,859 Added 485.09%
16,716 $2.15 Million
Q4 2023

Feb 02, 2024

BUY
$87.78 - $105.45 $62,411 - $74,974
711 Added 33.13%
2,857 $295,000
Q3 2023

Nov 09, 2023

BUY
$90.94 - $199.54 $195,157 - $428,212
2,146 New
2,146 $195,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $240B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Headlands Technologies LLC Portfolio

Follow Headlands Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Headlands Technologies LLC with notifications on news.